PubMed · 2015 · 31 citations · 9 references
MedicineEndocrinologyPharmacologyClinical PharmacologyEndocrine PharmacotherapyOncology PharmacotherapyAdverse Drug ReactionsEndocrine Drug Adverse EffectsEndocrine SequelaeEndocrine Toxicity ManagementPancreatic DiseasesPancreatic DisordersPancreatitis RiskRecurrent Acute PancreatitisTherapeutic Rechallenge
CONTEXT: Pancreatitis is a very rare adverse effect of tamoxifen with only six cases of tamoxifen-associated pancreatitis reported in the English literature until now. In these cases, rechallenge with tamoxifen was not carried out. CASE REPORT: We report a case of recurrent severe acute pancreatitis in a 44-year-old female induced by tamoxifen therapy and review the literature with regards to tamoxifen-associated pancreatitis. CONCLUSION: Clinicians should be aware of the risks of developing severe acute pancreatitis when using tamoxifen therapy. If tamoxifen is suspected as the probable causative agent, rechallenge with this drug should be prohibited.
9
Chirag Trivedi, C. S. Pitchumoni · Journal of Clinical Gastroenterology · 2005 · 367 citations
Tamoxifen-induced severe hypertriglyceridemia and pancreatitis
Moses Elisaf, Konstantina Nakou, Georgé Liamis et al. · Annals of Oncology · 2000 · 66 citations · Full text
Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen
Masakuni Noguchi, T Taniya, Kiyoshi Tajiri et al. · British journal of surgery · 1987 · 38 citations